These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 23810735

  • 1. CD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis.
    Lim HJ, Park JS, Cho YJ, Yoon HI, Park KU, Lee CT, Lee JH.
    Tuberculosis (Edinb); 2013 Sep; 93(5):523-8. PubMed ID: 23810735
    [Abstract] [Full Text] [Related]

  • 2. Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis.
    Li N, Xie WP, Kong H, Min R, Hu CM, Zhou XB, Lu ZM, Ji XH, Wang H.
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1230-8. PubMed ID: 26459539
    [Abstract] [Full Text] [Related]

  • 3. Frequency of Circulating CD4+Ki67+HLA-DR- T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture Conversion.
    Ferrian S, Ross M, Conradie F, Vally Omar S, Ismail N, Little F, Kaplan G, Fallows D, Gray CM.
    Front Immunol; 2018 Oct; 9():2438. PubMed ID: 30410488
    [Abstract] [Full Text] [Related]

  • 4. Decrease in CD4+CD25+FoxP3+ Treg cells after pulmonary resection in the treatment of cavity multidrug-resistant tuberculosis.
    Wu YE, Peng WG, Cai YM, Zheng GZ, Zheng GL, Lin JH, Zhang SW, Li K.
    Int J Infect Dis; 2010 Sep; 14(9):e815-22. PubMed ID: 20655262
    [Abstract] [Full Text] [Related]

  • 5. CD4+ regulatory T cells and CD4+ activated T cells in new active and relapse tuberculosis.
    Ndishimye P, Zakham F, Musanabaganwa C, Migambi P, Mihai C, Soritau O, El Mzibri M, Pop CM, Mutesa L.
    Cell Mol Biol (Noisy-le-grand); 2019 Dec 31; 65(8):18-22. PubMed ID: 32133974
    [Abstract] [Full Text] [Related]

  • 6. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
    Chen X, Zhou B, Li M, Deng Q, Wu X, Le X, Wu C, Larmonier N, Zhang W, Zhang H, Wang H, Katsanis E.
    Clin Immunol; 2007 Apr 31; 123(1):50-9. PubMed ID: 17234458
    [Abstract] [Full Text] [Related]

  • 7. Effective expansion of forkhead box P3⁺ regulatory T cells via early secreted antigenic target 6 and antigen 85 complex B from Mycobacterium tuberculosis.
    Wu YE, Du ZR, Cai YM, Peng WG, Zheng GZ, Zheng GL, Wu LB, Li K.
    Mol Med Rep; 2015 Apr 31; 11(4):3134-42. PubMed ID: 25483347
    [Abstract] [Full Text] [Related]

  • 8. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
    Zewdie M, Howe R, Hoff ST, Doherty TM, Getachew N, Tarekegne A, Tessema B, Yamuah L, Aseffa A, Abebe M.
    Tuberculosis (Edinb); 2016 Sep 31; 100():61-68. PubMed ID: 27553411
    [Abstract] [Full Text] [Related]

  • 9. [Expression of mRNA transcription factors RORC2 and FoxP3 in lymphocytes in patients with pulmonary tuberculosis].
    Kononova TE, Urazova OI, Novitskiĭ VV, Churina EG, Zakharova PA.
    Tsitologiia; 2015 Sep 31; 57(1):56-61. PubMed ID: 25872376
    [Abstract] [Full Text] [Related]

  • 10. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.
    Rathored J, Sharma SK, Singh B, Banavaliker JN, Sreenivas V, Srivastava AK, Mohan A, Sachan A, Harinarayan CV, Goswami R.
    Int J Tuberc Lung Dis; 2012 Nov 31; 16(11):1522-8. PubMed ID: 22990231
    [Abstract] [Full Text] [Related]

  • 11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar 31; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 12. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
    Teixeira L, Perkins MD, Johnson JL, Keller R, Palaci M, do Valle Dettoni V, Canedo Rocha LM, Debanne S, Talbot E, Dietze R.
    Int J Tuberc Lung Dis; 2001 Apr 31; 5(4):321-8. PubMed ID: 11334250
    [Abstract] [Full Text] [Related]

  • 13. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.
    Int J Tuberc Lung Dis; 2013 Apr 31; 17(4):526-31. PubMed ID: 23485387
    [Abstract] [Full Text] [Related]

  • 14. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May 31; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 15. [The changes and the significance of cellular immune function in peripheral blood of patients with multidrug-resistant and extensively drug-resistant pulmonary tuberculosis].
    Yang Y, Tang SJ, Zhang Q, Sun H, Liu YD, Hao XH, Yao L, Gu J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Feb 31; 34(2):109-13. PubMed ID: 21426728
    [Abstract] [Full Text] [Related]

  • 16. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.
    de Araújo-Filho JA, Vasconcelos AC, Martins de Sousa E, Kipnis A, Ribeiro E, Junqueira-Kipnis AP.
    Tuberculosis (Edinb); 2008 Sep 31; 88(5):474-81. PubMed ID: 18676203
    [Abstract] [Full Text] [Related]

  • 17. Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10.
    Xu L, Cui G, Jia H, Zhu Y, Ding Y, Chen J, Lu C, Ye P, Gao H, Li L, Ma W, Lyu J, Diao H.
    J Transl Med; 2016 Jun 16; 14(1):179. PubMed ID: 27311307
    [Abstract] [Full Text] [Related]

  • 18. Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis.
    Cağatay T, Kiran B, Yurt S, Gülbaran Z, Kosar F, Cağatay P.
    Respirology; 2005 Jun 16; 10(3):290-4. PubMed ID: 15955139
    [Abstract] [Full Text] [Related]

  • 19. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
    Lee J, Lim HJ, Cho YJ, Park YS, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Yim JJ.
    Int J Tuberc Lung Dis; 2011 Oct 16; 15(10):1331-3. PubMed ID: 22283890
    [Abstract] [Full Text] [Related]

  • 20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 16; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.